Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$264.64M
Total Bought:
$69.15M
Total Sold:
$45.09M
Net Transaction:
+$24.06M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)65,59764,196-1,401$25.83M$27.61M10.43%+$1.78M
Disc Medicine, Inc.(IRON)254,803503,089+248,286$15.86M$22.67M8.57%+$6.81M
Crinetics Pharmaceuticals In660,143479,681-180,462$30.90M$21.48M8.12%-$9.42M
Vaxcyte, Inc.(PCVX)185,175215,680+30,505$12.65M$16.29M6.15%+$3.64M
Ascendis Pharma A/SADR(ASND)103,428113,224+9,796$15.64M$15.44M5.83%-$193.7K
Cytokinetics, Incorporated(CYTK)263,701272,036+8,335$18.49M$14.74M5.57%-$3.75M
BioMarin Pharmaceutical Inc.(BMRN)119,188178,589+59,401$10.41M$14.70M5.56%+$4.29M
Cogent Biosciences, Inc.(COGT)1,595,0211,673,919+78,898$10.72M$14.11M5.33%+$3.39M
Cargo Therapeutics Inc0856,849+856,849$0$14.07M5.32%+$14.07M
Kalvista Pharmaceuticals Inc1,441,9521,128,478-313,474$17.10M$13.29M5.02%-$3.81M
Celcuity Inc.(CELC)0760,941+760,941$0$12.46M4.71%+$12.46M
Merus N V376,629164,773-211,856$16.96M$9.75M3.68%-$7.21M
Syndax Pharmaceuticals, Inc.(SNDX)397,997419,654+21,657$9.47M$8.62M3.26%-$856.8K
ABIVAX Société AnonymeADS(ABVX)622,970627,760+4,790$8.91M$8.30M3.14%-$609.5K
Ironwood Pharmaceuticals, Inc.CL A(IRWD)944,9121,113,824+168,912$8.23M$7.26M2.74%-$968.1K
Amicus Therapeutics Inc
COM
898,381713,536-184,845$10.58M$7.08M2.67%-$3.50M
Anaptysbio Inc586,031249,609-336,422$13.20M$6.26M2.36%-$6.94M
Phathom Pharmaceuticals, Inc.(PHAT)500,987593,306+92,319$5.32M$6.11M2.31%+$790.6K
Iteos Therapeutics Inc387,095367,429-19,666$5.28M$5.45M2.06%+$172.7K
Inozyme Pharma Inc01,140,310+1,140,310$0$5.09M1.92%+$5.09M
Neumora Therapeutics, Inc.(NMRA)0390,084+390,084$0$3.83M1.45%+$3.83M
Enliven Therapeutics Inc0152,178+152,178$0$3.56M1.34%+$3.56M
Longboard Pharmaceuticals In071,442+71,442$0$1.93M0.73%+$1.93M
Rapport Therapeutics, Inc.(RAPP)070,000+70,000$0$1.63M0.62%+$1.63M
Morphic Hldg Inc85,63247,660-37,972$3.01M$1.62M0.61%-$1.39M
Contineum Therapeutics, Inc.CL A(CTNM)072,831+72,831$0$1.28M0.48%+$1.28M
Apellis Pharmaceuticals Inc
COM
71,4630-71,463$4.20M$0—-$4.20M
Cabaletta Bio, Inc.(CABA)173,1730-173,173$2.95M$0—-$2.95M
Geron Corporation(GERN)1,123,9950-1,123,995$3.71M$0—-$3.71M
Page 1 of 1
Saturn V Capital Management LP — 13F Holdings — Q2 2024 | TickerTrail